• United Therapeutics Corp., of Silver Spring, Md., reported total revenues of $243.8 million for the fourth quarter, with net income totaling $83.3 million, or $1.65 per share. Those figures were well above consensus estimates, which had predicted $233 million in revenue and earnings per share of $1.25.